Modification phosphodiester bonds

The activity of glutamine synthetase is also controlled by reversible covalent modification —the attachment of an AMP unit by a phosphodiester bond to the hydroxyl group of a specific tyrosine residue in each subunit (Figure 24.26). This adenylylated enzyme is less active and more susceptible to cumulative feedback inhibition than is the deadenylylated form. The covalently attached AMP unit is removed from the adenylylated enzyme by phosphorolysis. The attachment of an AMP unit is the final step in an enzymatic cascade that is initiated several steps back by reactants and immediate products in glutamine synthesis. 

While the introduction of heteroatoms at non-bridging positions of the phosphodiester bond can be easily achieved, modifications involving bridging positions of the phosphorus centre often require elaborated chemical approaches. A novel P3 - N5 dinucleotide linkage (74) has now been described. Thymidine-3 -W-(thymidine-5 -yl)-/7-phosphonamidate (74a) was synthesised by reacting the appropriately protected 3 -aryl /7-phosphonate derivative of thymidine with the 3 -protected-5 -amino-thymidine in the presence of pivaloyl chloride. The phosphonamidate was subsequently oxidised to yield the dinucleoside phosphoramidate (74b) and dinucleoside phosphoramidothioate derivatives (74c). 

With respect to pharmacokinetics it is obvious that biotransformation of natural or only slightly modified natural oligonucleotides - mainly by action of nucleases - is a major obstacle towards application of such compounds. It is not surprising that first of all a variety of modifications of the labile phosphodiester bond has been developed, with phosphorothioate and methylphosphonate groups being hitherto the most successful approaches (see section 6). This report will also include structures such as peptide nucleic acids (PNAs), which are promising bio-isosteres of natural lead structures (see section 10.1). 

Micrococcal nuclease is an extracellular enzyme of Staphylococcus aureus that hydrolyzes specific phosphodiester bonds of both RNA and DNA. The protein is a convenient model for studies of conformational stability, effects of ligand binding, chemical modification, hydrolytic mechanism, and X-ray crystallographic analyses. ... 

Research on structural modification of PLs to achieve the aforementioned nutritional and functional properties has increased prominently. The structural modification of PLs can be done enzymatically using phospholipases and lipases. Phospholipase A (PLAj) cleaves the fatty acid at the sn-l position, while Phospholipase A (PLA ) cleaves the fatty acid at the sn-2 position. Phospholipase C (PLC) hydrolyses the phosphodiester bond between the glycerol backbone and phosphate. On the other hand, phospholipase D (PLD) hydrolyses the phosphodiester bond between the phosphate and the head group. Lipases can also be used to modify the fatty acid composition at sn-l and sn-2 positions of phospholipids. Guo and co-workers (2005) and Nieuwenhuyzen and Thomas (2008) have provided a detailed review on enzymatic modification of phospholipids for functional applications and human nutrition. 

EcoRI restriction (R) and modification (M) enzymes are probably the best studied of all type II R-M systems in terms of structure and function. R EcoRI specifically recognizes a palindromic hexanucleotide sequence, 5 -GAATTC-3, in dsDNA and cuts the phosphodiester bond between G and A, producing a 5 protruding four-base termini. EcoRI is the first restriction endonuclease (ENase) to be purified to homogeneity and in a large quantity. EcoRI ENase serves as the prototype of type II ENases in a detailed understanding of their endonucleolytic actions and protein-DNA interactions. 

Modified short DNA and RNA molecules with novel bond linkages between the bases have been designed with the aim to use the antisense approach by binding to the RNA template in the hTR subunit(s) to prevent or halt transcription and thereby act as competitive inhibitors of telomerase activity. Hence, the hTR RNA template is unavailable to hTERT for reverse transcription (52). The various types of sugar phosphodiester backbone modifications in these molecules are intended to confer certain desirable characteristics or properties, such as intracellular penetration, superior binding affinity, and therefore specificity, to the hTR RNA template and in order to enable intact delivery to their target. 

---